According to the 2024 American Diabetes Association Standards of Care, GLP-1 receptor agonists have become first line pharmacotherapy for most patients with type 2 diabetes mellitus (T2DM), including those with concomitant atherosclerotic cardiovascular disease (ASCVD), indicators of high ASCVD risk, or chronic kidney disease
resources, A.P., G.A., S.N.V., G.V., S.K.P., R.H.A.C., and E.L
In particular, over the last decade, attention has been drawn to the application of keratopigmentation to change eye colour in healthy eyes (Figure 3) (Ali et al., 2016)
Your muscles are sore and tired, and you can barely lift the weights in front of you at the gym